F2RL3 and steatosis: Par-4-/- mice did not exhibit any hepatic changes at 3 months of age, but beginning at about 6 months, the livers from Par-4-/- mice had significantly larger weights and showed increased steatosis relative to the livers from Par-4+/+ mice (Figure S1D).